Investors Three-year Losses Continue as Pfizer (NYSE:PFE) Dips a Further 7.9% This Week, Earnings Continue to Decline
Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?
Pfizer Options Spot-On: On May 9th, 111.82K Contracts Were Traded, With 3.55 Million Open Interest
Catalyst Watch: China Trade Talks, Walmart Earnings, and Take-Two on the GTA Hot Seat
Option Traders Moderately Bearish in Pfizer (PFE), With Shares Down $-0.07 (-0.33%) Near $22.46.
Pfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?
Daily short sale tracking: Bank Bradesco SA(prefer share ADS)'s short volume increased by 28 million, with a short sale ratio of 18%
US, UK to Seek Preferential Treatment on Pharmaceutical Tariffs
Was Jim Cramer Right About Pfizer (PFE)?
AI empowers the FDA! Drug approvals hit the 'fast-forward' button, and a large number of pharmaceutical companies may welcome a 'Gold' period.
The USA Food and Drug Administration (FDA) announced an accelerated plan on Thursday to fully implement AI applications across all subsidiary institutions by June 30, aiming to significantly expedite the approval process for new pharmaceuticals.
If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?
FDA to Speed up AI Rollout to Accelerate Drug Reviews
FDA Advisory Panel to Discuss Makeup of Updated COVID Shots
Viatris Hits Main Goals in Phase 3 Trial for Birth Control Patch
Pfizer To Go Ex-Dividend On May 9th, 2025 With 0.43 USD Dividend Per Share
Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report
Pfizer Options Spot-On: On May 7th, 106.28K Contracts Were Traded, With 3.48 Million Open Interest
Jim Cramer on Pfizer (PFE): "Trying Big Targets, but New Wins Still Elusive"
Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says -- Barrons.com
Pfizer, J&J, Genentech Drugs Subject of FDA Advisory Panel Meeting This Month